China Universal China Universal Nasdaq Biotechnology Index ETF (QDII) (SHA:513290)

Assets	n/a
Expense Ratio	n/a
PE Ratio	17.76
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+39.65%

Volume	101,182,300
Open	1.791
Previous Close	1.776
Day's Range	1.757 - 1.793
52-Week Low	1.228
52-Week High	1.931
Beta	0.10
Holdings	252
Inception Date	Aug 15, 2022

About 513290

513290.SS was created on 2022-08-15 by China Universal. The fund's investment portfolio concentrates primarily on health care equity. Tightly track the target index, and pursue the minimization of tracking deviation and tracking error.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 513290
• Provider: China Universal
• Index Tracked: NASDAQ / Biotechnology

Performance

513290 had a total return of 39.65% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.39%.

Top 10 Holdings

41.33% of assets

Name	Symbol	Weight
Vertex Pharmaceuticals Incorporated	VRTX	8.25%
Amgen Inc.	AMGN	8.00%
Gilead Sciences, Inc.	GILD	6.99%
Regeneron Pharmaceuticals, Inc.	REGN	4.56%
Alnylam Pharmaceuticals, Inc.	ALNY	2.85%
Revolution Medicines, Inc.	RVMD	2.82%
Biogen Inc.	BIIB	2.26%
Moderna, Inc.	MRNA	1.97%
argenx SE	ARGX	1.82%
Roivant Sciences Ltd.	ROIV	1.81%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error